Literature DB >> 9650680

Treatment of type I spinal muscular atrophy with noninvasive ventilation and gastrostomy feeding.

D J Birnkrant1, J F Pope, J E Martin, A H Repucci, R M Eiben.   

Abstract

Type I spinal muscular atrophy (SMA) is a rapidly progressive, degenerative neuromuscular disease of infancy. In severe SMA, weakness, hypotonia, and bulbar involvement lead to progressive respiratory insufficiency and swallowing dysfunction, which are frequently complicated by aspirations. There are few studies reported in the literature that address the respiratory management of type I SMA. This article reports the results of treating four patients with infantile SMA with noninvasive positive pressure ventilation and gastrostomy feeding. All patients had gastroesophageal reflux disease, which was managed medically. Despite these therapies, survival was only 1 to 3.5 months after presenting with severe aspirations. The treatment strategy, which can be effective in less rapidly progressive neuromuscular diseases, did not alter the very poor prognosis of type I SMA. The treatment options are reviewed, and a strategy designed to optimize quality of life for infants with this fatal disease is presented.

Entities:  

Mesh:

Year:  1998        PMID: 9650680     DOI: 10.1016/s0887-8994(97)00227-0

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

Review 1.  Ethics and decision making in end stage lung disease.

Authors:  A K Simonds
Journal:  Thorax       Date:  2003-03       Impact factor: 9.139

2.  Spinal muscular atrophy--type I.

Authors:  M K M Hardart; R D Truog
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

Review 3.  Spinal Muscular Atrophy.

Authors:  Stephen J Kolb; John T Kissel
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

Review 4.  Spinal muscular atrophy: diagnosis and management in a new therapeutic era.

Authors:  W David Arnold; Darine Kassar; John T Kissel
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

5.  SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage.

Authors:  Mohini Jangi; Christina Fleet; Patrick Cullen; Shipra V Gupta; Shila Mekhoubad; Eric Chiao; Norm Allaire; C Frank Bennett; Frank Rigo; Adrian R Krainer; Jessica A Hurt; John P Carulli; John F Staropoli
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-07       Impact factor: 11.205

Review 6.  Diagnostic radiology in paediatric palliative care.

Authors:  Preena Patel; Michelle Koh; Lucinda Carr; Kieran McHugh
Journal:  Pediatr Radiol       Date:  2014-01-07

7.  Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors.

Authors:  Amanda Carré; Candice Empey
Journal:  J Genet Couns       Date:  2015-08-08       Impact factor: 2.537

Review 8.  Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates.

Authors:  Marianna A Maretina; Galina Y Zheleznyakova; Kristina M Lanko; Anna A Egorova; Vladislav S Baranov; Anton V Kiselev
Journal:  Curr Genomics       Date:  2018-08       Impact factor: 2.236

9.  Long-term Non-Invasive Ventilation in Infants: A Systematic Review and Meta-Analysis.

Authors:  Prabhjot K Bedi; Maria Luisa Castro-Codesal; Robin Featherstone; Mohammed M AlBalawi; Bashar Alkhaledi; Anita L Kozyrskyj; Carlos Flores-Mir; Joanna E MacLean
Journal:  Front Pediatr       Date:  2018-02-12       Impact factor: 3.418

10.  Respiratory support attitudes among pediatric intensive care staff for spinal muscular atrophy patients in Saudi Arabia.

Authors:  Mohamad-Hani A Temsah; Fahad M Al-Sohime; Fahad A Bashiri; Ayman A Al-Eyadhy; Gamal M Hasan; Ali A Alhaboob
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.